{"id":"divalproex-mood-stabilizer","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Somnolence"},{"rate":"5-10%","effect":"Weight gain"},{"rate":"5-10%","effect":"Hair loss"},{"rate":"2-5%","effect":"Rash"},{"rate":"1-2%","effect":"Thrombocytopenia"},{"rate":"1-2%","effect":"Liver enzyme elevations"},{"rate":"<1%","effect":"Pancreatitis"}]},"_chembl":{"chemblId":"CHEMBL2105613","moleculeType":"Small molecule","molecularWeight":"310.41"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by inhibiting the reuptake of certain neurotransmitters, such as serotonin and norepinephrine, and also by reducing the release of excitatory neurotransmitters like glutamate. This leads to a decrease in the excitatory activity of neurons, which can help to stabilize mood.","oneSentence":"Divalproex works by stabilizing mood by modulating the activity of neurotransmitters in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:45:52.312Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mania associated with bipolar disorder"},{"name":"Seizure disorders"}]},"trialDetails":[{"nctId":"NCT07140913","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Mania, Bipolar Disorder","enrollment":424},{"nctId":"NCT06993662","phase":"PHASE1","title":"The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rakitzi, Stavroula","startDate":"2025-06-02","conditions":"Anxiety, Depression, Obsessive-compulsive Disorder","enrollment":107},{"nctId":"NCT07047651","phase":"PHASE4","title":"Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.","status":"RECRUITING","sponsor":"Dr. Stavroula Rakitzi","startDate":"2025-06-04","conditions":"Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder","enrollment":40},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT00306475","phase":"PHASE4","title":"Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2006-03","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":60},{"nctId":"NCT02473250","phase":"PHASE4","title":"Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2015-01","conditions":"Bipolar Disorder","enrollment":40},{"nctId":"NCT06729541","phase":"NA","title":"Development and Application of Precision Treatment Strategies for Common Mental Disorders","status":"RECRUITING","sponsor":"Peking University","startDate":"2024-11-11","conditions":"Depression - Major Depressive Disorder, Schizophrenia Disorders, Bipolar Disorder (BD)","enrollment":600},{"nctId":"NCT00581009","phase":"PHASE1, PHASE2","title":"The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2001-05-30","conditions":"Major Depressive Disorder, Bipolar Disorder","enrollment":49},{"nctId":"NCT04218981","phase":"NA","title":"Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders","status":"COMPLETED","sponsor":"Central South University","startDate":"2020-01-15","conditions":"Common Mental Disorder","enrollment":200},{"nctId":"NCT00221429","phase":"PHASE3","title":"Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2001-03","conditions":"Bipolar Disorder","enrollment":153},{"nctId":"NCT05481957","phase":"PHASE4","title":"Vortioxetine Adjunctive Treatment in Bipolar Depression","status":"COMPLETED","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2022-03-01","conditions":"Bipolar Depression","enrollment":131},{"nctId":"NCT00312494","phase":"PHASE3","title":"3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-04","conditions":"Bipolar Disorder","enrollment":680},{"nctId":"NCT01588457","phase":"PHASE4","title":"Sequential Multiple Assignment Treatment for Bipolar Disorder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2011-06","conditions":"Bipolar I Disorder, Bipolar II Disorder","enrollment":112},{"nctId":"NCT04486092","phase":"NA","title":"Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2015-02","conditions":"Bipolar Disorder","enrollment":200},{"nctId":"NCT01272531","phase":"","title":"Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2011-04","conditions":"Bipolar Affective Disorder","enrollment":560},{"nctId":"NCT00667745","phase":"PHASE4","title":"Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2008-04","conditions":"Bipolar Disorder","enrollment":283},{"nctId":"NCT02593643","phase":"EARLY_PHASE1","title":"Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-01","conditions":"Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder","enrollment":9},{"nctId":"NCT01463111","phase":"NA","title":"Decision-Making in Bipolar Disorder","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-05","conditions":"Bipolar Disorder","enrollment":37},{"nctId":"NCT00562861","phase":"PHASE2, PHASE3","title":"Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2007-11","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":119},{"nctId":"NCT00664976","phase":"NA","title":"Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2008-04","conditions":"Bipolar Disorder","enrollment":73},{"nctId":"NCT01689389","phase":"","title":"Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-12","conditions":"Schizophrenia, Bipolar Episodes","enrollment":2292},{"nctId":"NCT02300051","phase":"NA","title":"Intervention Study for Individuals With Compulsive Sexual Behavior","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2011-02","conditions":"Compulsive Sexual Behavior","enrollment":135},{"nctId":"NCT01977300","phase":"PHASE3","title":"Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2003-01","conditions":"Bipolar I Disorder","enrollment":159},{"nctId":"NCT00176202","phase":"PHASE3","title":"Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2003-04","conditions":"Bipolar Disorder","enrollment":65},{"nctId":"NCT00108576","phase":"PHASE3","title":"Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2003-10","conditions":"PTSD","enrollment":101},{"nctId":"NCT00332098","phase":"PHASE3","title":"Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2006-08","conditions":"Bipolar Disorder","enrollment":145},{"nctId":"NCT00114686","phase":"PHASE3","title":"Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-01","conditions":"Bipolar I Disorder, Alcohol Dependence","enrollment":350},{"nctId":"NCT00857584","phase":"PHASE3","title":"Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-05","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":27},{"nctId":"NCT00309686","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-04","conditions":"Affective Psychosis, Bipolar, Bipolar Disorder, Mania","enrollment":300},{"nctId":"NCT00266630","phase":"PHASE3","title":"Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2005-11","conditions":"Manic or Mixed Episode Associated With Bipolar I Disorder","enrollment":139},{"nctId":"NCT00402324","phase":"PHASE4","title":"A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-12","conditions":"Bipolar I Disorder","enrollment":202},{"nctId":"NCT00107731","phase":"PHASE3","title":"Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-04","conditions":"Bipolar I Disorder","enrollment":710},{"nctId":"NCT00081380","phase":"PHASE3","title":"Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-03","conditions":"Bipolar Disorder","enrollment":710},{"nctId":"NCT00012558","phase":"NA","title":"Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1998-09","conditions":"Bipolar Disorder","enrollment":5000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":398,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"divalproex (mood stabilizer)","genericName":"divalproex (mood stabilizer)","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Divalproex works by stabilizing mood by modulating the activity of neurotransmitters in the brain. Used for Mania associated with bipolar disorder, Seizure disorders.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}